Prasad K, Atherton J, Smith G, McKenna W, Frenneaux M, Nihoyannopoulos P
Heart. 1999; 82 Suppl 3:III8-III15.
PMID: 10534325
PMC: 1766516.
DOI: 10.1136/hrt.82.2008.iii8.
Seiler C, Jenni R, Vassalli G, Turina M, Hess O
Br Heart J. 1995; 74(5):508-16.
PMID: 8562235
PMC: 484070.
DOI: 10.1136/hrt.74.5.508.
Doi Y
Br Heart J. 1980; 44(5):606-7.
PMID: 7437207
PMC: 482454.
DOI: 10.1136/hrt.44.5.606.
Bjarnason I, Hardarson T, Jonsson S
Br Heart J. 1982; 48(3):198-203.
PMID: 7201843
PMC: 481229.
DOI: 10.1136/hrt.48.3.198.
Loperfido F, Fiorilli R, Digaetano A, Di Gennaro M, Santarelli P, Bellocci F
Br Heart J. 1982; 47(6):588-95.
PMID: 7200794
PMC: 481186.
DOI: 10.1136/hrt.47.6.588.
Mode of inheritance of hypertrophic cardiomyopathy in Iceland. Echocardiographic study.
Bjarnason I, Jonsson S, Hardarson T
Br Heart J. 1982; 47(2):122-9.
PMID: 7199347
PMC: 481109.
DOI: 10.1136/hrt.47.2.122.
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.
McKenna W, Harris L, Perez G, Krikler D, Oakley C, Goodwin J
Br Heart J. 1981; 46(2):173-8.
PMID: 7196769
PMC: 482624.
DOI: 10.1136/hrt.46.2.173.
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
McKenna W, England D, Doi Y, Deanfield J, Oakley C, Goodwin J
Br Heart J. 1981; 46(2):168-72.
PMID: 7196768
PMC: 482623.
DOI: 10.1136/hrt.46.2.168.
Prediction of mortality and serious ventricular arrhythmia in hypertrophic cardiomyopathy. An echocardiographic study.
Doi Y, McKenna W, Chetty S, Oakley C, Goodwin J
Br Heart J. 1980; 44(2):150-7.
PMID: 7191710
PMC: 482374.
DOI: 10.1136/hrt.44.2.150.
Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine.
Griffiths B, Hughes P, Dowdle R, Stephens M
Thorax. 1982; 37(9):711-2.
PMID: 6891504
PMC: 459412.
DOI: 10.1136/thx.37.9.711.
Hypertrophic cardiomyopathy: a common disease with a good prognosis. Five year experience of a district general hospital.
Shapiro L, Zezulka A
Br Heart J. 1983; 50(6):530-3.
PMID: 6686058
PMC: 481455.
DOI: 10.1136/hrt.50.6.530.
Hypertrophic cardiomyopathy: an important cause of sudden death.
McKenna W, Deanfield J
Arch Dis Child. 1984; 59(10):971-5.
PMID: 6541894
PMC: 1628861.
DOI: 10.1136/adc.59.10.971.
Cardiomyopathy in western Denmark.
Bagger J, Baandrup U, Rasmussen K, Moller M, Vesterlund T
Br Heart J. 1984; 52(3):327-31.
PMID: 6540593
PMC: 481633.
DOI: 10.1136/hrt.52.3.327.
Echocardiographic differentiation of hypertensive heart disease and hypertrophic cardiomyopathy.
Doi Y, Deanfield J, McKenna W, Dargie H, Oakley C, Goodwin J
Br Heart J. 1980; 44(4):395-400.
PMID: 6448611
PMC: 482417.
DOI: 10.1136/hrt.44.4.395.
The frontiers of cardiomyopathy.
Goodwin J
Br Heart J. 1982; 48(1):1-18.
PMID: 6123334
PMC: 481195.
DOI: 10.1136/hrt.48.1.1.
Phonoechocardiography and intracardiac phonocardiography in hypertrophic cardiomyopathy.
Shaver J, Alvares R, Reddy P, Salerni R
Postgrad Med J. 1986; 62(728):537-43.
PMID: 3774689
PMC: 2418790.
DOI: 10.1136/pgmj.62.728.537.
Treadmill exercise test in children with cardiomyopathy and postmyocarditic myocardial hypertrophy.
Sumitomo N, Ito S, Harada K, Kobayashi H, OKUNI M
Heart Vessels. 1986; 2(1):47-50.
PMID: 3722084
DOI: 10.1007/BF02060245.
Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association.
Symons C, Fortune F, Greenbaum R, Dandona P
Br Heart J. 1985; 54(5):539-42.
PMID: 2932135
PMC: 481943.
DOI: 10.1136/hrt.54.5.539.
Hypertrophic cardiomyopathy: long-term effects of propranolol versus verapamil in preventing sudden death in "low-risk" patients.
Pelliccia F, Cianfrocca C, Romeo F, Reale A
Cardiovasc Drugs Ther. 1990; 4(6):1515-8.
PMID: 2081144
DOI: 10.1007/BF02026500.